Does the media favor SKIN or CV?

In the previous week, Beauty Health had 13 more articles in the media than CapsoVision. MarketBeat recorded 15 mentions for Beauty Health and 2 mentions for CapsoVision. Beauty Health's average media sentiment score of 1.01 beat CapsoVision's score of 0.93 indicating that Beauty Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beauty Health 8 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive CapsoVision 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, SKIN or CNXU?

Conexeu Sciences has lower revenue, but higher earnings than Beauty Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Beauty Health $296.12M 0.29 -$9.52M -$0.17 N/A Conexeu Sciences N/A N/A N/A N/A N/A

Does the media favor SKIN or CNXU?

In the previous week, Beauty Health had 8 more articles in the media than Conexeu Sciences. MarketBeat recorded 15 mentions for Beauty Health and 7 mentions for Conexeu Sciences. Beauty Health's average media sentiment score of 1.01 beat Conexeu Sciences' score of 0.90 indicating that Beauty Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beauty Health 8 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Conexeu Sciences 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SKIN or TMCI?

In the previous week, Beauty Health had 13 more articles in the media than Treace Medical Concepts. MarketBeat recorded 15 mentions for Beauty Health and 2 mentions for Treace Medical Concepts. Beauty Health's average media sentiment score of 1.01 beat Treace Medical Concepts' score of 0.84 indicating that Beauty Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beauty Health 8 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Treace Medical Concepts 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Beauty Health (SKIN) Competitors

$0.66 +0.02 (+3.17%)

Closing price 06/26/2026 04:00 PM Eastern

Extended Trading

$0.62 -0.04 (-6.06%)

As of 06/26/2026 07:03 PM Eastern

Compare

SKIN vs. CV, ELMD, SGHT, CNXU, and TMCI

Should you buy Beauty Health stock or one of its competitors? MarketBeat compares Beauty Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Beauty Health include CapsoVision (CV), Electromed (ELMD), Sight Sciences (SGHT), Conexeu Sciences (CNXU), and Treace Medical Concepts (TMCI). These companies are all part of the "medical equipment" industry.

How does Beauty Health compare to CapsoVision?

Beauty Health (NASDAQ:SKIN) and CapsoVision (NASDAQ:CV) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

Beauty Health has a net margin of -2.03% compared to CapsoVision's net margin of -198.87%. CapsoVision's return on equity of 0.00% beat Beauty Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beauty Health	-2.03%	-9.38%	-1.21%
CapsoVision	-198.87%	N/A	-136.03%

In the previous week, Beauty Health had 13 more articles in the media than CapsoVision. MarketBeat recorded 15 mentions for Beauty Health and 2 mentions for CapsoVision. Beauty Health's average media sentiment score of 1.01 beat CapsoVision's score of 0.93 indicating that Beauty Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beauty Health	8 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
CapsoVision	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Beauty Health currently has a consensus price target of $2.02, suggesting a potential upside of 206.06%. CapsoVision has a consensus price target of $8.50, suggesting a potential upside of 14.73%. Given Beauty Health's higher probable upside, research analysts plainly believe Beauty Health is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Beauty Health has higher revenue and earnings than CapsoVision. Beauty Health is trading at a lower price-to-earnings ratio than CapsoVision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beauty Health	$296.12M	0.29	-$9.52M	-$0.17	N/A
CapsoVision	$13.55M	27.32	-$25.32M	-$2.34	N/A

93.3% of Beauty Health shares are owned by institutional investors. 40.3% of Beauty Health shares are owned by company insiders. Comparatively, 2.3% of CapsoVision shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Beauty Health beats CapsoVision on 10 of the 15 factors compared between the two stocks.

How does Beauty Health compare to Electromed?

Beauty Health (NASDAQ:SKIN) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership.

Beauty Health currently has a consensus price target of $2.02, suggesting a potential upside of 206.06%. Electromed has a consensus price target of $37.50, suggesting a potential downside of 9.55%. Given Beauty Health's higher possible upside, equities analysts clearly believe Beauty Health is more favorable than Electromed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Electromed	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25

93.3% of Beauty Health shares are owned by institutional investors. Comparatively, 40.8% of Electromed shares are owned by institutional investors. 40.3% of Beauty Health shares are owned by company insiders. Comparatively, 10.5% of Electromed shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Electromed has a net margin of 11.34% compared to Beauty Health's net margin of -2.03%. Electromed's return on equity of 15.71% beat Beauty Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beauty Health	-2.03%	-9.38%	-1.21%
Electromed	11.34%	15.71%	13.37%

In the previous week, Beauty Health had 15 more articles in the media than Electromed. MarketBeat recorded 15 mentions for Beauty Health and 0 mentions for Electromed. Beauty Health's average media sentiment score of 1.01 beat Electromed's score of 0.00 indicating that Beauty Health is being referred to more favorably in the media.

Company	Overall Sentiment
Beauty Health	Positive
Electromed	Neutral

Beauty Health has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market. Comparatively, Electromed has a beta of 0.53, indicating that its share price is 47% less volatile than the broader market.

Electromed has lower revenue, but higher earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beauty Health	$296.12M	0.29	-$9.52M	-$0.17	N/A
Electromed	$71.75M	4.78	$5.15M	$1.17	35.44

Summary

Electromed beats Beauty Health on 10 of the 17 factors compared between the two stocks.

How does Beauty Health compare to Sight Sciences?

Sight Sciences (NASDAQ:SGHT) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.

Sight Sciences currently has a consensus price target of $8.14, indicating a potential upside of 43.12%. Beauty Health has a consensus price target of $2.02, indicating a potential upside of 206.06%. Given Beauty Health's higher probable upside, analysts clearly believe Beauty Health is more favorable than Sight Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sight Sciences	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.44
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Sight Sciences has a beta of 2.41, suggesting that its stock price is 141% more volatile than the broader market. Comparatively, Beauty Health has a beta of 1.09, suggesting that its stock price is 9% more volatile than the broader market.

In the previous week, Beauty Health had 14 more articles in the media than Sight Sciences. MarketBeat recorded 15 mentions for Beauty Health and 1 mentions for Sight Sciences. Sight Sciences' average media sentiment score of 1.87 beat Beauty Health's score of 1.01 indicating that Sight Sciences is being referred to more favorably in the media.

Company	Overall Sentiment
Sight Sciences	Very Positive
Beauty Health	Positive

Beauty Health has a net margin of -2.03% compared to Sight Sciences' net margin of -46.83%. Beauty Health's return on equity of -9.38% beat Sight Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sight Sciences	-46.83%	-52.34%	-28.49%
Beauty Health	-2.03%	-9.38%	-1.21%

Beauty Health has higher revenue and earnings than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sight Sciences	$79.55M	3.89	-$38.43M	-$0.71	N/A
Beauty Health	$296.12M	0.29	-$9.52M	-$0.17	N/A

55.5% of Sight Sciences shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 30.9% of Sight Sciences shares are held by company insiders. Comparatively, 40.3% of Beauty Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Beauty Health beats Sight Sciences on 11 of the 16 factors compared between the two stocks.

How does Beauty Health compare to Conexeu Sciences?

Beauty Health (NASDAQ:SKIN) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, risk and media sentiment.

Beauty Health currently has a consensus price target of $2.02, indicating a potential upside of 206.06%. Conexeu Sciences has a consensus price target of $20.00, indicating a potential upside of 82.48%. Given Beauty Health's higher possible upside, equities research analysts plainly believe Beauty Health is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Conexeu Sciences	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Beauty Health had 8 more articles in the media than Conexeu Sciences. MarketBeat recorded 15 mentions for Beauty Health and 7 mentions for Conexeu Sciences. Beauty Health's average media sentiment score of 1.01 beat Conexeu Sciences' score of 0.90 indicating that Beauty Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beauty Health	8 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Conexeu Sciences	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

93.3% of Beauty Health shares are held by institutional investors. 40.3% of Beauty Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Conexeu Sciences has a net margin of 0.00% compared to Beauty Health's net margin of -2.03%. Conexeu Sciences' return on equity of 0.00% beat Beauty Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beauty Health	-2.03%	-9.38%	-1.21%
Conexeu Sciences	N/A	N/A	N/A

Conexeu Sciences has lower revenue, but higher earnings than Beauty Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beauty Health	$296.12M	0.29	-$9.52M	-$0.17	N/A
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A

Summary

Beauty Health beats Conexeu Sciences on 6 of the 10 factors compared between the two stocks.

How does Beauty Health compare to Treace Medical Concepts?

Beauty Health (NASDAQ:SKIN) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations.

Beauty Health has a beta of 1.09, meaning that its share price is 9% more volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market.

93.3% of Beauty Health shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 40.3% of Beauty Health shares are held by company insiders. Comparatively, 23.4% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Beauty Health has higher revenue and earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beauty Health	$296.12M	0.29	-$9.52M	-$0.17	N/A
Treace Medical Concepts	$207.32M	1.40	-$59M	-$0.97	N/A

Beauty Health currently has a consensus price target of $2.02, indicating a potential upside of 206.06%. Treace Medical Concepts has a consensus price target of $4.77, indicating a potential upside of 6.95%. Given Beauty Health's stronger consensus rating and higher possible upside, analysts plainly believe Beauty Health is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

In the previous week, Beauty Health had 13 more articles in the media than Treace Medical Concepts. MarketBeat recorded 15 mentions for Beauty Health and 2 mentions for Treace Medical Concepts. Beauty Health's average media sentiment score of 1.01 beat Treace Medical Concepts' score of 0.84 indicating that Beauty Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beauty Health	8 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Treace Medical Concepts	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Beauty Health has a net margin of -2.03% compared to Treace Medical Concepts' net margin of -29.44%. Beauty Health's return on equity of -9.38% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beauty Health	-2.03%	-9.38%	-1.21%
Treace Medical Concepts	-29.44%	-67.04%	-30.28%

Summary

Beauty Health beats Treace Medical Concepts on 13 of the 15 factors compared between the two stocks.

Get Beauty Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SKIN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SKIN vs. The Competition

Export

Metric	Beauty Health	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$82.91M	$9.28B	$6.70B	$12.21B
Dividend Yield	N/A	1.70%	2.67%	6.13%
P/E Ratio	-3.88	25.95	25.90	24.18
Price / Sales	0.29	22.89	579.30	113.38
Price / Cash	4.19	109.31	46.99	54.37
Price / Book	1.38	5.99	10.78	6.36
Net Income	-$9.52M	$179.69M	$3.58B	$337.99M
7 Day Performance	-0.42%	4.28%	2.22%	0.10%
1 Month Performance	-15.77%	6.47%	1.12%	-0.11%
1 Year Performance	-66.15%	14.74%	34.29%	27.61%

Beauty Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SKIN Beauty Health	2.913 of 5 stars	$0.66 +3.2%	$2.02 +206.1%	-66.0%	$82.91M	$296.12M	N/A	1,030	Positive News Analyst Forecast High Trading Volume
CV CapsoVision	0.798 of 5 stars	$6.62 +2.2%	$8.50 +28.3%	N/A	$329.96M	$13.56M	N/A	90	News Coverage
ELMD Electromed	0.5722 of 5 stars	$38.92 +1.4%	$37.50 -3.7%	+91.3%	$322.27M	$71.75M	51.89	160
SGHT Sight Sciences	3.7604 of 5 stars	$5.40 +3.1%	$8.14 +50.8%	+33.9%	$293.81M	$77.36M	N/A	210	Positive News
CNXU Conexeu Sciences	4.6646 of 5 stars	$10.83 -11.1%	$20.00 +84.7%	N/A	$293.05M	N/A	N/A	4	News Coverage Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SKIN) was last updated on 6/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Beauty Health (SKIN) Competitors

SKIN vs. CV, ELMD, SGHT, CNXU, and TMCI

How does Beauty Health compare to CapsoVision?

Summary

How does Beauty Health compare to Electromed?

Summary

How does Beauty Health compare to Sight Sciences?

Summary

How does Beauty Health compare to Conexeu Sciences?

Summary

How does Beauty Health compare to Treace Medical Concepts?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKIN vs. The Competition

Beauty Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Beauty Health (SKIN) Competitors

SKIN vs. CV, ELMD, SGHT, CNXU, and TMCI

How does Beauty Health compare to CapsoVision?

Is SKIN or CV more profitable?

Does the media favor SKIN or CV?

Do analysts prefer SKIN or CV?

Which has preferable earnings and valuation, SKIN or CV?

Do institutionals and insiders hold more shares of SKIN or CV?

Summary

How does Beauty Health compare to Electromed?

Do analysts prefer SKIN or ELMD?

Do insiders & institutionals hold more shares of SKIN or ELMD?

Is SKIN or ELMD more profitable?

Does the media favor SKIN or ELMD?

Which has more volatility & risk, SKIN or ELMD?

Which has better valuation & earnings, SKIN or ELMD?

Summary

How does Beauty Health compare to Sight Sciences?

Do analysts recommend SGHT or SKIN?

Which has more risk & volatility, SGHT or SKIN?

Does the media favor SGHT or SKIN?

Is SGHT or SKIN more profitable?

Which has stronger earnings & valuation, SGHT or SKIN?

Do insiders and institutionals believe in SGHT or SKIN?

Summary

How does Beauty Health compare to Conexeu Sciences?

Do analysts recommend SKIN or CNXU?

Does the media favor SKIN or CNXU?

Do institutionals & insiders believe in SKIN or CNXU?

Is SKIN or CNXU more profitable?

Which has stronger valuation & earnings, SKIN or CNXU?

Summary

How does Beauty Health compare to Treace Medical Concepts?

Which has more risk and volatility, SKIN or TMCI?

Do insiders & institutionals have more ownership in SKIN or TMCI?

Which has stronger earnings & valuation, SKIN or TMCI?

Do analysts prefer SKIN or TMCI?

Does the media prefer SKIN or TMCI?

Is SKIN or TMCI more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKIN vs. The Competition

Beauty Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools